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Common surgical approaches for medial maxillectomy 
include lateral rhinotomy and midfacial degloving. Lateral 
rhinotomy provides excellent surgical exposure but leaves 
a bulging scar on the face. Despite its own limitations, 
midfacial degloving has been preferred to lateral rhinotomy 
because it does not leave any external scar on the face¹. 
The aim of this study is to evaluate the cosmetic results and 
surgical exposure access of midfacial degloving. Treatment 
morbidity was evaluated through: post operative hospital 
stay length, blood transfusion needs, complications, pre and 
post operative hemoglobin levels, disease recurrence, nasal 
packing, type of suture and antibiotics. Retrospective study 
was carried out with sixteen patients treated at the Hospital 
Geral de Fortaleza SESA/SUS from December 1999 through 
November 2003. Based on the results, we may conclude that 
midfacial degloving is effective to treat extensive nasal cavity 
lesions and paranasal sinuses with reduced post operative 
morbidity.
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INTRODUCTION
Nasosinusal tumors, specially those with important 
invasive components, require an aggressive and broad 
surgical management, one that allows the surgeon to have 
a clear view of the tumor margins so that the procedure 
may become as curative as possible. Conventional maxil-
lectomy, lateral rhinotomy and the Weber-Fergusson or 
Diffenbach approaches are still worldly used; however 
in many cases they have been replaced by the mid-facial 
degloving, which avoids facial scars. This approach has 
been used for about 25 years now and its use is increas-
ing in the treatment of extensive benign lesions of the 
rhinosinusal region, for some malignant neoplasms of this 
area, and also to provide access to the nasopharynx and 
infratemporal fossa2.
The surgical approach is the following:
After orotracheal intubation, nasal topic vasocon-
strictor drops and local infiltration, the procedure starts 
with a transfixating incision and a bilateral intercartilagi-
nous incision. Nasal dorsum tissues, anterior wall of the 
maxillary sinus, glabella and frontal bone are lifted through 
the intercartilaginous incision, they are then extended 
laterally towards the nasal cavity floor until they touch 
the caudal portion of the transfixating incision bilaterally, 
finishing the incision in a circle. Afterwards, a sublabial 
incision is carried out from the first molar, all the way to 
the corresponding contralateral tooth. This incision hits 
the muco-periosteum and continues with the intranasal 
incision in the nostril region. A periosteum elevator is 
used to raise the tissues bilaterally until one reaches the 
inferior orbital rim, taking the necessary care to protect the 
infraorbitary nerve and vessels. The flap, which includes 
the inferior lateral cartilage and the columellae, is raised all 
the way to the glabella, medial cantus region and forehead, 
in a way as to expose all the mid-facial skeleton³.
For what we showed by the technique description, 
the degloving approach bears the great advantage of 
exposing all the intranasal and nasosinusal structures for 
surgical intervention, and this represents a decisive fac-
tor when one considers malignant diseases, in which the 
margins have to be free, and besides, it bears excellent 
cosmetic results because there is no skin incision. 
OBJECTIVE
Our goal is to describe the cosmetic results and 
those of a better intraoperative access for nasosinusal 
surgeries via degloving, as well as assessing the post-opera-
tive morbidity of patients who underwent this procedure, 
we carried out a study with the patients admitted to the 
Hospital Geral de Fortaleza SESA/SUS, bearing nasoan-
giofibroma, nasosinusal inverted papilloma, stesioneu-
roblastoma, cystic adenoid carcinoma, clivus chordoma, 
cholesterol granuloma and gigantic cells granuloma.
MATERIALS AND METHODS
In order to assess post-operative morbidity and 
cosmetic results based on the surgical access of patients 
operated through degloving, we carried out a retrospec-
tive study of 16 patients operated at the Hospital Geral de 
Fortaleza SESA/SUS, from December 1999 to November of 
2003, at the Head and Neck Department, under general 
anesthesia. The patients had nasoangiofibroma (9 patients), 
nasosinusal inverted papilloma (2 patients), stesioneurob-
lastoma (1 patient), cystic adenoid carcinoma (1 patient), 
clivus chordoma (1 patient), cholesterol granuloma (1 
patient) and giant cell granuloma (1 patient), confirmed by 
histopathology. This research was carried out with medical 
chart assessment from the hospital archives and the filling 
out of a standardized protocol including the following data: 
name, chart number, date of surgery, lesion topography, 
pre-operative hemoglobin, post-operative hospital stay, use 
of antibiotic agents, nasal packing duration, surgical wire 
used, need for blood transfusion, complications and follow 
up time without recurrence (through nasofibroscopy).
RESULTS
The patients in this series had average age of 25.5 
years (varying between 12 and 76 years) (Table 1). All 
the patients required nasal packing with average duration 
of 4.5 days (between 2 and 9). In 15 patients there was 
a reduction on the hemoglobin levels at an average of 
2.07mg/dL (between 0.7 and 4.3 mg/dL). All angiofibroma 
patients presented reductions in blood count levels, at 
an average of 2.01mg/dL (0.7 - 3.8mg/dL). Nine patients 
required blood transfusion during surgery, of which 6 had 
angiofibroma, and the average volume of blood transfused 
was of 700mL (between 300-1,200mL). All patients used 
prophylactic or therapeutic antibiotics, and the average use 
was of 6.5 days (between 3-12 days). Of the antibiotics 
used, the most common was Cephalothin (10 of the 16 
patients) (Table 2). In order to suture the nasal vestibule 
and the oral mucosa, we used Vicryl® 4.0 wire in 15 
patients. Only 1 patient was sutured with Monocryl 4.0 
suture wire, and in two patients we used both Vicryl 4.0 
and Silk 4.0. There were complications in 7 patients, all 
minor. So far, only 2 of the 16 patients had recurrence of 
the disease they were operated for. The average hospital 
stay was of 7.3 days (between 4-16 days) post-op (Table 
3). The post-op follow up was carried out with flexible 
video-nasofibroscopy, and all diagnoses were confirmed 
by histopathology. 
DISCUSSION
Lateral rhinotomy is a traditional approach for nasal 
cavity and paranasal sinus tumor surgeries. This approach 
provides an excellent surgical exposure; notwithstanding, 
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Table 1. Relation of patients, surgery performed, age and lesion topography.
Patient Surgery Age Lesion topography 
1 Resection of nasopharyngeal angiofibroma 14 years old Nasopharynx
2 Resection of nasopharyngeal angiofibroma 19 years old Nasopharynx
3 Medial ethmoidectomy and maxillectomy 15 years old Nasal cavity
4 Resection of nasopharyngeal angiofibroma 18 years old Nasopharynx
5 Resection of clivus chordoma 31 years old Clivus
6 ethmoidectomy and maxillectomy 57 years old Maxillary sinus
7 Resection of nasopharyngeal angiofibroma 20 years old Nasopharynx
8 Resection of nasopharyngeal angiofibroma 20 years old Nasopharynx
9 Resection of nasopharyngeal angiofibroma 16 years old Nasopharynx
10 Resection of nasopharyngeal angiofibroma 15 years old Nasopharynx
11 Resection of nasopharyngeal angiofibroma 19 years old Nasopharynx
12 Maxillectomy 26 years old Maxillary sinus
13 Resection of nasosinusal inverted papilloma 76 years old Nasal cavity
14 Resection of nasosinusal inverted papilloma 42 years old Nasal cavity
15 Resection of stesioneuroblastoma 12 years old Nasal cavity
16 Resection of nasopharyngeal angiofibroma 23 years old Nasopharynx
Table 2. Relation of pre and post operative hemoglobin, blood transfusion, nasal packing and antibiotics.
Patient Hb pre-op Hb post-op Transfusion Nasal packing Antibiotic
1 12,0 10,9 900 ml 3 days Cephalothin 7 days
2 12,1 11,4 No 2 days Cephalothin 7 days
3 11,5 12,8 600 ml 2 days Cephalothin 5 days 
4 15,5 12,0 600mL 6 days Cephalothin 7 days
5 13,2 8,93 1200ml 5 days Cephtriaxon 10 days
6 14,5 11,4 No 3 days Ampicilin 12 days
7 12,7 11,0 600ml 3 days Cephalothin 06 days
8 16,0 14,7 300ml 3 days Cephalothin 03 days
9 16,3 12,5 300mL 5 days Cephalothin 3days
10 15,2 13,8 No 6 days Cephalexin 10 days
11 12,0 10,0 No 4 days Cephalothin 04 days
12 13,9 12,7 No 9 days Cephalexin 10 days
13 14,0 12,7 No 5 days Clindamicina  04 days
14 12,4 10,6 600mL 4 days Clindamycin/Amycacin 06 days
15 14,0 12,5 No 5 days Cephalothin 07days
16 11,6 9,0 1200ml 3 days Cephalothin 03 days
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Table 3. Relation of the surgical wire used in oral and nasal mucosas, hospital stay after surgery, recurrence and complications.
Patient Surgical wire Hospital stay Recurrence Complications
1 Vicryl 4.0 7 days No. 55 months Bleeding
2 Vicryl 4.0 7 days No. 40 months No
3 Vicryl 4.0 5 days Yes. 29 months No
4 Vicryl 4.0 7 days No. 31 months Suture dehiscence
5 Vicryl 4.0 16 days Yes. 6 months No 
6 Vicryl 4.0 12 days No. 37 months Oroantral fistula
7 Vicryl 4.0 6 days No. 28 months Nasal alae drop
8 Vicryl 4.0 and Silk 4.0 6 days No. 24 months Trismus
9 Vicryl 4.0 and Silk 4.0 6 days No. 24 months No
10 Vicryl 4.0 7 days No. 21 months Epistaxis and septum perforation
11 Vicryl 4.0 4 days No. 19 months No
12 Vicryl 4.0 10 days No. 9 months Trismus
13 Monocryl 4.0 5 days No. 15 months No 
14 Vicryl 4.0 6 days No. 12 months No
15 Vicryl 4.0 8 days Yes. 6 months No
16 Vicryl 4.0 5 days No. 8 months No
Figure 1. Approach to nasoangiofibroma through mid-facial deglov-
ing.
Figure 2. Approach to stesioneuroblastoma through mid-facial de-
gloving.
even with such advantage, its use is limited, because it 
leaves a prominent scar on the face. The degloving ap-
proach was first described in 1974, by Casson et al.¹ and 
has become very popular because of its major advan-
tages of avoiding facial incisions and providing bilateral 
exposure of the nasal cavity. Thus, the mid-facial deglov-
ing approach has been used as a first option for medial 
maxillectomy, radical maxillectomy and non-complicated 
cranio-facial surgeries4-6.
Some changes to the degloving approach have been 
described, in order to avoid vestibular stenosis, which is 
the most frequent and significant complication7.
The standard procedure comprises an extensive 
gengivobuccal incision, a transfixating septal incision, an 
intercartilaginous incision and an incision in the nostril. 
The vestibular stenosis occurs as a consequence of the 
circumferential incision that is made in the nasal vestibule 
during the procedure. 
Of the sixteen patients operated in our department, 
there were post-operative complications in seven, but none 
of them related to nasal vestibule stenosis, thus showing 
that the surgical procedure in itself, based on surgeon’s 
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experience and the wire used (Vicryl® in most of the cases) 
provides good cosmetic outcome. Only one patient had 
suture dehiscence. The suture wire used in the vestibular 
region is an important analysis point to be considered, in 
order to guarantee the success of the procedure as far as 
physiology and nasal cosmetics are concerned8.
Although it has been already established that one 
hour more of surgery time increases by twofold the in-
cidence of infection and it is certainly one more factor 
related to an increase in injuries and their repercussion, 
operative time is still debated. There is no relationship 
between surgery time and post-operative complications, 
death or long term survival. 
Thus, it is known that one of the inconveniencies 
of the type of surgery under study is that it takes longer 
than its endoscopic counterpart, and the latter is a feasible 
and very much efficient alternative for the treatment of 
nasal cavity tumors in their initial stage, because it is less 
aggressive and brings less complications to the patient’s 
post-op recovery. Notwithstanding, considering larger 
lesions, even if benign, the endoscopic approach is not 
adequate. 
Another drawback is that since this represents an 
extensive surgery, there is more bleeding, requiring a 
greater need for volume replacement, thus 9 of the 16 
patients received red blood cells concentrate transfusion, 
at an average of 700mL/patient, and there was a fall in 
hemoglobin levels in 15 patients, at an average of 2.07mg/
dL. However, it is worth highlighting that of these nine, 
six patients had angiofibroma (the average blood volume 
transfused was 650mL of red blood cells concentrate), a 
vascular lesion that by itself causes active bleeding, and 
from the nine patients with angiofibroma, all had reduc-
tions in their blood element counts. All patients with this 
lesion underwent tumor embolization before surgery. In 
assessing bleeding of the remaining tumors, 4 patients did 
not require blood transfusion and 3 required an average 
of 800mL. Therefore, the assessment of intra-operative 
bleeding is much more related to tumor histology type then 
the surgical technique used. Although the literature shows 
that intraoperative blood transfusion may be an indicator 
of bad prognosis - reducing post-operative survival, this 
has not been found in the present study. 
Besides, nasal packing was necessary in all patients, 
with an average of 4.5 days in hospital stay. Even then, 
the post-operative hospitalization time was of 7.3 days in 
average, and only 2 patients had recurrent disease. These 
two factors alone, coupled to the advantage of not leav-
ing scars, shows that although degloving does have the 
aforementioned inconvenient points, it is efficient in the 
treatment of extensive lesions involving the nasal cavity 
and paranasal sinuses. 
CONCLUSION
With the data presented in this study, we may con-
clude that the degloving approach to resect nasosinusal 
tumors is effective and bears the advantages of broad sur-
gical exposure, excellent cosmetic results, very low post-
operative complication rates and low recurrence rates. 
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